Skip to content

Cameron Turtle, Chief Executive Officer at Spyre Therapeutics, sold SYRE on Jul 1, 2026

Data as of Oct 16

▼ SELL$52.5K590 shares at $88.91Cameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.
Watch SYRE
Traded
Jul 1, 2026
Disclosed
Jul 2, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Cameron Turtle, Chief Executive Officer at Spyre Therapeutics, sold SYRE on Jul 1, 2026TRADEDDISCLOSED
SYRESimilar stocks (XLV — its sector index fund), rebased to SYRE's price on the disclosure day
SYRE since disclosure
−7.8%
after the sale
Similar stocks (XLV) since disclosure
+7.9%
XLV — its sector index fund

Change in closing price from Jul 2, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$373Kdisclosed Jul 2 · filed 1 day after the trade
  2. ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$890Kdisclosed Jul 2 · filed 1 day after the trade

See every trade on SYRE →